Neural Monitoring of the Superior Laryngeal Nerve in Thyroid Surgery
Intra-operative Monitoring of the External Branch of the Superior Laryngeal Nerve (EBSLN) During Thyroid Surgery: Does it Improve Voice Preservation?
1 other identifier
interventional
9
1 country
1
Brief Summary
Thyroid surgeons place an enormous amount of importance and rightly so to the preservation of the recurrent laryngeal nerve (RLN) during thyroidectomies. A good knowledge of the anatomy of the nerve and meticulous dissection technique and intraoperative identification of the nerve are crucial to the anatomic and functional integrity of the nerve. The use of intraoperative neural monitoring to aid the surgeon in the identification of the RLN has gained acceptance and is considered standard practice in several units. However, lesser emphasis has been placed historically on the identification and preservation of the external branch of the superior laryngeal nerve (EBSLN) during thyroid surgery. The EBSLN supplies the cricothyroid muscle that controls pitch variation during phonation. Unlike damage to the recurrent laryngeal nerve which manifests readily as vocal cord paralysis, intraoperative damage to EBSLN is difficult to assess postoperatively as visual assessment of the larynx is not indicative of the integrity of the nerve. Injury of the EBSLN can cause weakness or complete paralysis of the ipsilateral cricothyroid muscle. Patients may report a deeper voice or an inability to produce high pitched sounds. Patients may also complain of weakness, tightness of the voice, and require extra effort to speak. Of note, voice changes with EBSLN injury are subtle in the general population but can be devastating in patients who depend on their voice for a living. Importantly, EBSLN injury is reported in upto 50% of thyroid surgery in contrast to 12% of recurrent laryngeal nerve injury during thyroid surgery. The new guidelines published in the Laryngoscope recommend routine intraoperative neural monitoring of EBSLN. The Investigators have a functional system in use currently for monitoring recurrent laryngeal nerve intraoperatively and propose to study the impact of monitoring the EBSLN using the same neural monitoring device to improve voice results following thyroid surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2015
CompletedFirst Posted
Study publicly available on registry
March 20, 2015
CompletedStudy Start
First participant enrolled
September 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedJune 19, 2019
June 1, 2019
3.1 years
March 16, 2015
June 17, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Intact external branch of the superior laryngeal nerve
Review and feedback via questionnaire of superior laryngeal nerve
6 months
Study Arms (2)
Monitoring
EXPERIMENTALintraoperative EBSLN monitoring will take place
Non-Monitoring
NO INTERVENTIONNo intraoperative EBSLN monitoring will take place (standard practice)
Interventions
Eligibility Criteria
You may qualify if:
- Patients undergoing diagnostic hemithyroidectomies (thyroid nodules 5 cm or less).
- age 18 and over
- able to provide informed consent
You may not qualify if:
- Patients who develop a recurrent laryngeal nerve palsy following surgery will be excluded from the study.
- Patients who withdraw consent during or after study
- Patients with pre-existing laryngeal pathology like reinkes edema, vocal cord nodules, laryngeal inflammation, previous laryngeal surgery etc
- Pregnant women (confirmed by history and routine pregnancy test)
- Those unable to give informed consent
- Previous major neck surgery such as neck dissections, laryngeal surgery, carotid endarterectomies, parathyroid and thyroid surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Royal Wolverhampton NHS Trust
Wolverhampton, West Midlands, WV10 0QP, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2015
First Posted
March 20, 2015
Study Start
September 9, 2015
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
June 19, 2019
Record last verified: 2019-06